Literature DB >> 2185911

Pulmonary hypertension in connective tissue disease. Clinical analysis of sixty patients in multi-institutional study.

R Kasukawa1, T Nishimaki, T Takagi, S Miyawaki, R Yokohari, T Tsunematsu.   

Abstract

Clinical features and prognosis of sixty patients with connective tissue disease accompanied by pulmonary hypertension (PH) (26 MCTD, 20 SLE, and 14 PSS) reported retrospectively by multi-institutions were compared. Though the obtained data were incomplete and lacking in uniformity, no significant difference in the clinical features among the three diseases were observed except high incidence of pulmonary fibrosis and low % VC in PSS and PH patients. Statistically significant difference, however, was observed between live and dead patients of three diseases gathered in post sternal pain, pulmonary diastolic murmur, right ventricular hypertrophy on ECG and mean pressure of pulmonary artery. Higher incidence of anti-nRNP antibody was observed in SLE with PH and PSS with PH patients than with the general population. A quicker occurrence of PH and shorter survival time were observed in MCTD patients with PH than in SLE and PSS patients with PH.

Entities:  

Mesh:

Year:  1990        PMID: 2185911     DOI: 10.1007/bf02030243

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  16 in total

1.  Lupus cor pulmonale with electron microscope and immunofluroescent antibody studies.

Authors:  P P Yeo; R Sinniah
Journal:  Ann Rheum Dis       Date:  1975-10       Impact factor: 19.103

2.  Pulmonary hypertension in systemic lupus erythematosus: a report of three cases.

Authors:  R A Asherson; D Hackett; A E Gharavi; E N Harris; H G Kennedy; G R Hughes
Journal:  J Rheumatol       Date:  1986-04       Impact factor: 4.666

3.  Pulmonary hypertension and systemic lupus erythematosus.

Authors:  R A Asherson; C M Oakley
Journal:  J Rheumatol       Date:  1986-02       Impact factor: 4.666

4.  Anti-nRNP and anti-Sm antibodies.

Authors:  G C Sharp
Journal:  Arthritis Rheum       Date:  1982-07

5.  Fatal pulmonary hypertension and resolving immune-complex glomerulonephritis in mixed connective tissue disease. A case report and review of the literature.

Authors:  M B Jones; R K Osterholm; R B Wilson; F H Martin; J R Commers; J D Bachmayer
Journal:  Am J Med       Date:  1978-11       Impact factor: 4.965

6.  Pulmonary vascular disease in systemic lupus erythematosus.

Authors:  A O Fayemi
Journal:  Am J Clin Pathol       Date:  1976-03       Impact factor: 2.493

7.  Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee.

Authors: 
Journal:  Arthritis Rheum       Date:  1980-05

8.  Immunopathologic and clinical studies in pulmonary hypertension associated with systemic lupus erythematosus.

Authors:  F P Quismorio; O Sharma; M Koss; T Boylen; A W Edmiston; P J Thornton; D Tatter
Journal:  Semin Arthritis Rheum       Date:  1984-05       Impact factor: 5.532

Review 9.  Pulmonary hypertension in systemic lupus erythematosus: report of four cases and review of the literature.

Authors:  H D Perez; N Kramer
Journal:  Semin Arthritis Rheum       Date:  1981-08       Impact factor: 5.532

Review 10.  Pulmonary hypertension in a patient with mixed connective tissue disease: clinical and pathologic findings, and review of literature.

Authors:  F M Graziano; L C Friedman; J Grossman
Journal:  Clin Exp Rheumatol       Date:  1983 Jul-Sep       Impact factor: 4.473

View more
  8 in total

Review 1.  Pulmonary hypertension in primary Sjögren's syndrome: report of a case and review of the literature.

Authors:  M Bertoni; L Niccoli; G Porciello; L Storri; C Nannini; A Manes; M Palazzini; N Galiè; F Cantini
Journal:  Clin Rheumatol       Date:  2005-05-19       Impact factor: 2.980

2.  Survival study by organ disorders in 306 Japanese patients with systemic lupus erythematosus: results from a single center.

Authors:  M Funauchi; H Shimadzu; C Tamaki; T Yamagata; Y Nozaki; M Sugiyama; S Ikoma; K Kinoshita
Journal:  Rheumatol Int       Date:  2006-08-31       Impact factor: 2.631

3.  Pulmonary hypertension in connective tissue disease.

Authors:  M Demedts
Journal:  Clin Rheumatol       Date:  1990-03       Impact factor: 2.980

4.  Pulmonary hypertension in MCTD: report of two cases with anticardiolipin antibody.

Authors:  M Miyata; S Kida; T Kanno; K Suzuki; H Watanabe; S Kaise; T Nishimaki; Y Hosoda; R Kasukawa
Journal:  Clin Rheumatol       Date:  1992-06       Impact factor: 2.980

Review 5.  Pulmonary hypertension in rheumatic diseases: epidemiology and pathogenesis.

Authors:  Anupama Shahane
Journal:  Rheumatol Int       Date:  2013-01-19       Impact factor: 2.631

6.  Pulmonary Arterial Hypertension in Patients with Primary Sjögren's Syndrome.

Authors:  Senol Kobak; Sezai Kalkan; Bahadır Kirilmaz; Mehmet Orman; Ertuğurul Ercan
Journal:  Autoimmune Dis       Date:  2014-01-09

7.  Sex disparities in systemic sclerosis-associated pulmonary arterial hypertension: a cohort study.

Authors:  Christopher R Pasarikovski; John T Granton; Adrienne M Roos; Saghar Sadeghi; Amie T Kron; John Thenganatt; Jakov Moric; Cathy Chau; Sindhu R Johnson
Journal:  Arthritis Res Ther       Date:  2016-01-27       Impact factor: 5.156

8.  Management of multiple neurological complications in mixed connective tissue disease: A case report.

Authors:  Yulei Hao; Liangshu Feng; Yongliang Teng; Yingying Cheng; Jiachun Feng
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.